National Marrow Donor Program

National Marrow Donor Program, doing business as Be The Match, is a Minneapolis-based non-profit organization that operates the nation's largest bone marrow registry and delivers hematopoietic stem cell transplantation services to the federal government as a prime contractor (92% of recent awards) and as a subcontractor on clinical trial and research initiatives. Be The Match competes exclusively full-and-open; the organization holds no SBA set-aside designations and receives prime awards across multiple federal agencies on the strength of its specialized and unique capabilities in blood marrow and stem cell donor identification, tissue typing, stem cell collection and transportation, and transplant coordination.

Be The Match's customer concentration is dominated by the Health Resources and Services Administration (HRSA), which accounts for $490.9 million in combined potential value across 13 awards — 95% of the organization's total federal potential value. Within that HRSA portfolio, a single definitive contract anchors the relationship: a $123.7 million Single Point of Access-Coordinating Center (SPA-CC) contract under the C.W. Bill Young Cell Transplantation Program running through March 2028, complemented by an $8.9 million Office of Patient Affairs contract through the same program. Beyond HRSA, Be The Match maintains operational relationships with the Department of Veterans Affairs (8 awards, $8.1 million potential value, primarily unrelated donor search services and registry maintenance through Veterans Integrated Service Network 9 and VISN 20), the National Heart Lung and Blood Institute (13 awards, $6.3 million potential value for transplant research and laboratory services), the Department of the Army Medical Command (55 awards, $4.6 million potential value for marrow transplant services and research and innovation domain contracts), and the Air Force (40 purchase orders through Air Education and Training Command for peripheral blood stem cell collections). The top two customers by value (HRSA and NHLBI) jointly represent 99% of combined potential value while accounting for only 26 of 214 awards, indicating a concentrated customer base anchored by high-dollar-value definitive contracts and cooperative agreements rather than task-order vehicles.

Activity has remained relatively stable year over year across the past five years — averaging roughly 13 to 15 awards annually through 2024 — with a modest decline to nine awards in 2025 and four awards to date in 2026. Six awards reaching ultimate completion in the next twenty-four months carry a combined potential value of $135.4 million and present recompete opportunity; the largest is the SPA-CC contract completing in March 2028 and therefore outside the immediate recompete cliff. Be The Match's prime contract portfolio centers on purchase orders and definitive contracts ranging from firm fixed-price service agreements valued under $300,000 (bone marrow donor services and unrelated donor search contracts from VA and Defense Health Agency) to large-dollar cooperative agreements with HRSA and cooperative research grants from the Office of Naval Research. NAICS concentration runs heavily to "All Other Miscellaneous Ambulatory Health Care Services" (79 awards) and "Blood and Organ Banks" (69 awards), with PSC codes dominated by Medical-Other (86 awards) and Hematology & Oncology (25 awards), reflecting the organization's core mission.

Service Contract Inventory reporting captures $81.7 million in invoiced federal services revenue across prime contracts in FY2022–FY2024, with FY2022 at $32.2 million (59.1 FTEs), FY2023 at $26 million (74.7 FTEs), and FY2024 at $23.6 million (86.1 FTEs). On SCI-reportable prime contracts, government-paid hourly rates span from a 10th percentile of $52.68/hr through a median of $101.70/hr to a 90th percentile of $233.97/hr, consistent with a workforce mix of clinical operations staff, technical donor-matching specialists, and senior research personnel. Across SCI-reportable prime contracts, Be The Match self-performed 100% of reported hours with no named subcontractors, indicating a vertically integrated delivery model. In its subcontractor role (8% of total awards), Be The Match functions as a clinical-trial support provider and data-management contributor under primes The Medical College of Wisconsin, Beckman Coulter, and Fred Hutchinson Cancer Center, delivering services including Stem Cell Therapeutic Outcomes Database (SCTOD) support, CAR-T cell therapy trial logistics, and blood and marrow transplant clinical trials network participation.

Federal grant funding complements the contract footprint. Be The Match holds grant awards from the Office of Naval Research (CFDA 12.300, Basic and Applied Scientific Research) focused on development of medical technology for contingency response to marrow toxic substances — a $2.88 million project grant awarded in February 2025 and prior awards in 2021, 2022, and 2023 totaling $16.5 million or more across the series — and cooperative agreements from the National Heart Lung and Blood Institute (Pediatric Transplantation and Cellular Therapy Consortium research initiative, ultimate completion June 2031) and the National Institute of Allergy and Infectious Diseases (clinical and mechanistic studies of optimal preparative approaches to severe combined immunodeficiency in infants, ultimate completion May 2029). Be The Match participates as sub-recipient in a multi-year Blood and Marrow Transplant Clinical Trials Network Data Coordinating Center grant from The Medical College of Wisconsin and holds sub-grants from academic medical centers and the University of California San Francisco supporting research in immunogenomic data exchange and HLA/KIR genotyping standards.